Stefan Laufer Selected Research

delta (2,16)-5 alpha- androstadiene- 3,17- diol- 3,17- diacetate

6/2018

NB 06: From a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Laufer Research Topics

Disease

27	Neoplasms (Cancer) 12/2022 - 06/2005
11	Inflammation (Inflammations) 01/2021 - 09/2003
10	Osteoarthritis 09/2008 - 03/2002
5	Rheumatoid Arthritis 06/2021 - 01/2006
4	Edema (Dropsy) 04/2022 - 03/2013
4	Lung Neoplasms (Lung Cancer) 02/2019 - 11/2013
4	Breast Neoplasms (Breast Cancer) 04/2009 - 11/2007
3	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 01/2014
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2014
3	Liver Neoplasms (Liver Cancer) 01/2020 - 10/2014
3	Arthritis (Polyarthritis) 12/2019 - 06/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2016
3	Malaria 06/2015 - 01/2009
3	Hemolysis 01/2015 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 06/2017
2	COVID-19 01/2021 - 01/2020
2	Atherosclerosis 01/2021 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 06/2010
2	Carcinogenesis 04/2020 - 07/2019
2	Leukemia 01/2020 - 01/2017
2	Hypoxia (Hypoxemia) 12/2019 - 01/2017
2	Hypersensitivity (Allergy) 01/2019 - 01/2016
2	Infections 06/2018 - 06/2014
2	Neuralgia (Stump Neuralgia) 01/2016 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 08/2012 - 02/2008
2	Ulcer 04/2004 - 08/2002
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Cytokine Release Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Ischemia 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Coronavirus Infections 01/2022

Drug/Important Bio-Agent (IBA)

11	p38 Mitogen-Activated Protein KinasesIBA 12/2020 - 07/2009
10	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2015 - 03/2002
10	licofeloneIBA 08/2012 - 07/2002
9	Phosphotransferases (Kinase)IBA 01/2022 - 03/2013
9	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2005
8	Pharmaceutical PreparationsIBA 12/2022 - 02/2008
7	EnzymesIBA 04/2022 - 06/2005
7	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 05/2008 - 07/2002
6	CytokinesIBA 01/2022 - 03/2002
5	ErbB Receptors (EGF Receptor)IBA 02/2019 - 08/2012
5	NucleosidesIBA 04/2009 - 06/2005
5	RNA (Ribonucleic Acid)IBA 04/2009 - 06/2005
4	Interleukin-6 (Interleukin 6)IBA 09/2020 - 09/2003
4	Lipoxygenase (Lipoxygenase-1)IBA 04/2020 - 03/2002
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2005
4	Small Interfering RNA (siRNA)IBA 01/2016 - 11/2013
4	ProstaglandinsIBA 09/2008 - 07/2002
3	Mitogen-Activated Protein KinasesIBA 12/2020 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 07/2002
3	skepinone-LIBA 12/2019 - 01/2013
3	CarrageenanIBA 01/2018 - 03/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2015
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 01/2013
3	PhosphatidylserinesIBA 01/2015 - 01/2015
3	Annexin A5IBA 01/2015 - 01/2015
3	diacetyldichlorofluoresceinIBA 01/2015 - 01/2015
3	Hemoglobins (Hemoglobin)IBA 01/2015 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 03/2002
3	Leukotriene B4IBA 09/2003 - 03/2002
2	Neuroprotective AgentsIBA 03/2022 - 06/2020
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 12/2020 - 11/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 10/2014
2	fluoromisonidazoleIBA 12/2019 - 01/2017
2	Therapeutic UsesIBA 12/2019 - 03/2004
2	Protein Kinases (Protein Kinase)IBA 07/2019 - 04/2009
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2015
2	Mitogen-Activated Protein Kinase 14IBA 01/2017 - 06/2010
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 06/2010
2	LigandsIBA 01/2017 - 06/2015
2	Annexin A7 (Synexin)IBA 04/2015 - 01/2009
2	Dinoprostone (PGE2)FDA Link 04/2015 - 09/2003
2	LuciferinsIBA 01/2015 - 01/2013
2	Biological ProductsIBA 01/2015 - 01/2006
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 01/2012
2	(4- (5- (4- fluorophenyl)- 2- methylsulfanyl- 3H- imidazol- 4- yl)pyridin- 2- yl)- (1- phenylethyl)amineIBA 03/2014 - 01/2012
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 11/2013 - 07/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2012 - 04/2004
2	SB 203580IBA 01/2012 - 05/2009
2	Cyclooxygenase InhibitorsIBA 01/2009 - 06/2006
2	DNA (Deoxyribonucleic Acid)IBA 10/2008 - 11/2007
2	LeukotrienesIBA 09/2008 - 09/2003
2	Acetic Acid (Vinegar)FDA LinkGeneric 09/2008 - 05/2008
2	Tumor Biomarkers (Tumor Markers)IBA 06/2008 - 06/2005
2	Arachidonic Acid (Vitamin F)IBA 02/2008 - 09/2003
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006 - 03/2002
2	Cathepsin KIBA 01/2005 - 03/2004
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2003 - 03/2002
2	EicosanoidsIBA 09/2003 - 03/2002
1	Pregnane X ReceptorIBA 12/2022
1	Cytochrome P-450 CYP3AIBA 12/2022
1	Protein Kinase InhibitorsIBA 12/2022
1	TrypsinIBA 04/2022
1	Viral ProteinsIBA 01/2022
1	ElementsIBA 01/2022

Therapy/Procedure

15	Therapeutics 12/2022 - 04/2004
3	Drug Therapy (Chemotherapy) 12/2022 - 01/2012
1	Ligation 01/2022